Events

Kevin Outterson, Joe Larsen & Tim Jinks DRIVE-AB DRIVE-AB Final Conference: Revitalizing the antibiotic pipeline Crowne Plaza, Brussels 5-6 Sep 2017

John Rex ASM-ESCMID ASM-ESCMID Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance Boston, MA 6-8 Sep 2017

Tyler Merkeley G20 G20 Antibiotic R&D Hub Meeting Berlin 11-12 Sep 2017

Barry Eisenstein & John Rex FDA-CDRH FDA-CDRH workshop on diagnostic devices for detecting antimicrobial susceptibility & resistance FDA - Silver Spring, MD 13 Sep 2017

Tyler Merkeley & Christopher Houchens 3rd World Antimicrobial Resistance Congress Accelerating a diverse global portfolio of 20 innovative antibacterial products towards clinical development leveraging a public private partnership model Washington, DC 14-15 Sep 2017

Tyler Merkeley, Kevin Outterson & Dennis Dixon Panel: Non-Dilutive Funding and Other Unique Capital Sources McDermott, Will & Emery Life Sciences Dealmaking Symposium Royal Sonesta Boston Cambridge, MA 4 Oct 2017

Kevin Outterson IHSIP Forces Shaping the Future of Health & Healthcare Boston, MA 16 Oct 2017

Heather Shane BIO Investor Forum Panel: Addressing Antimicrobial Resistance: New Research and Funding Opportunities San Francisco, CA 17 Oct 2017

Tyler Merkeley Re-Entering Antibacterial Discovery and Development Summit @ Omni Parker House CARB-X: What does it mean to be Powered by CARB-X? Boston, MA 18-20 Oct 2017

Kevin Outterson World Conference of Science Journalists Bridging Science and Societies San Francisco, CA 26-30 Oct 2017